Crossmark

Cerebral embolic protection (CEP) during transcatheter aortic valve replacement (TAVR) is associated with a lower rate of stroke at a high-volume center

Crossref DOI link: https://doi.org/10.1007/s00392-025-02802-5

Published Online: 2025-11-24

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Paukovitsch, Michael https://orcid.org/0000-0002-8056-3908
Lorenz, Julia

Felbel, Dominik

Scheffler, Jinny

Krohn-Grimberghe, Marvin

Schneider, Leonhard Moritz

Mörike, Johannes

Rottbauer, Wolfgang

Buckert, Dominik
Funding

Funding for this research was provided by:

Universität Ulm
License Information

Text and Data Mining valid from 2025-11-24

Version of Record valid from 2025-11-24
More Information

Article History

Received: 29 March 2025

Accepted: 9 November 2025

First Online: 24 November 2025

Declarations

:

: This study was approved by the Ethics committee of Ulm University (local approval number: 283/21) and was performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

: Informed consent was obtained from all individual participants included in the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below